Finance

Delta Air Lines committed to Boeing MAX 10, doesn’t expect delivery soon By Reuters

By Lisa Barrington DUBAI (Reuters) - Delta Air Lines (NYSE:) is still committed to the Boeing (NYSE:) 737 MAX 10 model that...

Software stocks got pummeled this week on troubling earnings reports

Salesforce executives told investors that deals are shrinking or getting delayed. Dell said its margin is getting smaller. Okta highlighted macroeconomic challenges. And...

Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting By Investing.com

NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the Company or Y-mAbs) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on...

Robbins Geller Rudman & Dowd LLP Announces that Fastly, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit By Investing.com

SAN DIEGO, June 01, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fastly, Inc. (NYSE:...

Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology...

Tumors shrank in 91% of taletrectinib-treated patients with advanced ROS1-positive NSCLC who were ROS1 TKI-naïve and 52% of those who were ROS1 TKI-pretreated...

Why the price of chocolate’s key ingredient skyrocketed in 2024

Chocolate's key ingredient has soared in commodities markets throughout 2024. Spot prices for cocoa began the year around $4,200 an ounce, then hit...

Explainer-What S&P’s ratings downgrade means for France By Reuters

By Leigh Thomas PARIS (Reuters) - Standard & Poor's (S&P) decision to downgrade its rating on France's sovereign debt should in the...

U.S.-sanctioned ex-officer among Iranian candidates to replace Raisi By Reuters

DUBAI (Reuters) - U.S.-sanctioned former Revolutionary Guards commander Vahid Haghanian is among candidates who registered on Saturday to become Iran's next president...

Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemo By Investing.com

Separate & Distinct from HARMONi-2 Announcement, HARMONi-A Showed Clinically Meaningful and Statistically Significant Benefit: PFS Hazard Ratio of 0.46  For Subset of Patients...

Latest articles

spot_imgspot_img